Published in Healthcare Finance, Tax and Law Weekly, June 30th, 2004
"Successful preemptive cytomegalovirus (CMV) therapy in transplant patients depends on the availability of sensitive, specific, and timely diagnostic tests for CMV infections. The pp65 antigenemia assay has been used for this purpose with considerable success. Quantification of CMV DNA is currently regarded to be an alternative diagnostic approach," scientists in Netherlands report.
"The precise relationship between these two methods has still to be defined," suggested J.S. Kalpoe and coauthors, "but is essential to compare diagnostic results. This study compared the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.